Effective Artwork Management Key to Reducing the Risk of Pharmaceutical Product Recall

Share Article

Ireland's Perigord Group Set to Unveil the Latest Features of GLAMS, Global Artwork Management System, this Autumn at London and Munich Events

It has been well documented that the costs associated with pharmaceutical packaging can represent up to 70% of the cost of the finished product. In addition industry experts estimate that between 35 to 40 percent of all pharmaceutical product recalls are attributed to packaging and labeling errors and omissions. In fact, a recent report by AMR Research revealed that in a six-month period last year, the Food and Drug Administration statistics include 455 product recall notices, 51 percent of which were because of mislabeling, and 13 percent were because of faulty packaging.

In terms of artwork and packaging, expanding global markets mean pharmaceutical companies need to deal with localization issues such as language, cultural and regulatory requirements. The scramble for entry into the pharmerging markets, a phrase coined by market intelligence organisation IMS Health to describe emerging pharmaceutical markets, has also offered up some unique challenges.

Right First Time artwork and packaging can be crucial to entry into a new market or indeed the overall commercial success of a drug. Using the Perigord Group’s Artwork services and technology, GLAMS or Global Artwork Management System, companies can effectively manage and connect all stakeholders in the process including regulatory, marketing, affiliates, multiple artwork centers (both internal and external), approvers, procurement and print vendors.

GLAMS is a web-based Artwork Management System that was developed to manage and streamline the artwork process from concept through to printing. It places total control over artwork in the customer’s hands, enabling better management of costs and accelerating the customer’s time to market.

What’s more, GLAMS creates a central online storage area that accepts all files using recognized industry standards, to provide a single point of proof. GLAMS allows all involved parties to participate directly in the print production process to generate artwork in a unified tracking and management flow. GLAMS integrates with all aspects of the artwork life cycle according to and in compliance with relevant industry standards and the customer’s specific needs.
Autumn Releases

Perigord are set to unveil the latest features of GLAMS this autumn at events in London and Munich.

  •     Pharma Packaging and Labelling Europe 2011, 19th & 20th Sept, Munich, Germany.
  •     Pharma Labelling, 19-20th Oct, Covent Garden, London.
  •     Pharmaceutical Packaging and Labelling event, 2-3rd Nov, London.

Commenting on the new releases, Alan Leamy, Perigord Group, Chief Executive Officer said, “We’re looking forward to showcasing some exciting new features of GLAMS. Unlike other products in the market, our system has been validated and we believe this makes it a unique and best in class solution.'

About the Perigord Group
Founded in 1976, the Perigord Group now provides high quality, cost efficient artwork services to many leading pharmaceutical & healthcare companies. With headquarters in Dublin, Ireland, and with artwork production hubs in Dublin, Connecticut & Singapore and sales offices in Sacramento USA, Christchurch New Zealand and Sao Paulo Brazil the group’s pharmaceutical and healthcare customers now account for in excess of 70% of its annual revenue. The ability to continually deliver Right First Time artwork has been essential to the group’s growth within this sector

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Colm McGrath
colm.mcgrath@perigordgroup.com
006421440533
Email >
Visit website